A citation-based method for searching scientific literature

Hae Kyung Yang, Borami Kang, Seung-Hwan Lee, Kun-Ho Yoon, Byung-Hee Hwang, Kiyuk Chang, Kyungdo Han, Gunseog Kang, Jae Hyoung Cho. J Diabetes Complications 2015
Times Cited: 20







List of co-cited articles
115 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
233
50


Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
40

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, Toshiharu Ninomiya, Mark Cooper, Pavel Hamet, Giuseppe Mancia, Neil Poulter, Stephen Harrap, Mark Woodward,[...]. Diabetes Care 2014
185
30

HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.
Giuseppe Penno, Anna Solini, Enzo Bonora, Cecilia Fondelli, Emanuela Orsi, Gianpaolo Zerbini, Susanna Morano, Franco Cavalot, Olga Lamacchia, Luigi Laviola,[...]. Diabetes Care 2013
94
25

Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
Giuseppe Penno, Anna Solini, Giacomo Zoppini, Emanuela Orsi, Cecilia Fondelli, Gianpaolo Zerbini, Susanna Morano, Franco Cavalot, Olga Lamacchia, Roberto Trevisan,[...]. Cardiovasc Diabetol 2013
47
25

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
25

Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome - Optical Coherence Tomography Study.
Masaomi Gohbara, Kiyoshi Hibi, Takayuki Mitsuhashi, Nobuhiko Maejima, Noriaki Iwahashi, Shunsuke Kataoka, Eiichi Akiyama, Kengo Tsukahara, Masami Kosuge, Toshiaki Ebina,[...]. Circ J 2016
35
25

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
157
25

HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.
A Sugawara, K Kawai, S Motohashi, K Saito, S Kodama, Y Yachi, R Hirasawa, H Shimano, K Yamazaki, H Sone. Diabetologia 2012
66
20

Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Andrea O Y Luk, Ronald C W Ma, Eric S H Lau, Xilin Yang, Winnie W Y Lau, Linda W L Yu, Francis C C Chow, Juliana C N Chan, Wing-Yee So. Diabetes Metab Res Rev 2013
81
20

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
723
20


Association between HbA1c variability and mortality in patients with type 2 diabetes.
Toshiko Takao, Yutaka Matsuyama, Hiroyuki Yanagisawa, Masatoshi Kikuchi, Shoji Kawazu. J Diabetes Complications 2014
36
20

Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.
L Monnier, C Colette, S Dejager, D R Owens. Rev Endocr Metab Disord 2016
16
25


HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
C C Hsu, H Y Chang, M C Huang, S J Hwang, Y C Yang, Y S Lee, S J Shin, T Y Tai. Diabetologia 2012
63
15

A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
Johan Wadén, Carol Forsblom, Lena M Thorn, Daniel Gordin, Markku Saraheimo, Per-Henrik Groop. Diabetes 2009
145
15

Glucose variability: An emerging target for the treatment of diabetes mellitus.
Simona Frontoni, Paolo Di Bartolo, Angelo Avogaro, Emanuele Bosi, Giuseppe Paolisso, Antonio Ceriello. Diabetes Res Clin Pract 2013
89
15



HbA1C variability and the risk of renal status progression in Diabetes Mellitus: a meta-analysis.
Dongsheng Cheng, Yang Fei, Yumei Liu, Junhui Li, Qin Xue, Xiaoxia Wang, Niansong Wang. PLoS One 2014
28
15

The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Ji Eun Jun, Sang-Man Jin, Jongha Baek, Sewon Oh, Kyu Yeon Hur, Myung-Shik Lee, Moon-Kyu Lee, Jae Hyeon Kim. Cardiovasc Diabetol 2015
59
15

The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
Eric S Kilpatrick, Alan S Rigby, Stephen L Atkin. Diabetes Care 2006
234
15

Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
155
15


Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
15

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
T Nishikawa, D Edelstein, X L Du, S Yamagishi, T Matsumura, Y Kaneda, M A Yorek, D Beebe, P J Oates, H P Hammes,[...]. Nature 2000
15

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
15


Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
John M Lachin, Ionut Bebu, Richard M Bergenstal, Rodica Pop-Busui, F John Service, Bernard Zinman, David M Nathan. Diabetes Care 2017
84
15

Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.
I M E Wentholt, W Kulik, R P J Michels, J B L Hoekstra, J H DeVries. Diabetologia 2008
141
15

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
668
15

Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study.
Kamlesh Khunti, Melanie Davies, Azeem Majeed, Brian Larsen Thorsted, Michael Lyng Wolden, Sanjoy K Paul. Diabetes Care 2015
184
15


Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.
Elizabeth Selvin, Michael W Steffes, Hong Zhu, Kunihiro Matsushita, Lynne Wagenknecht, James Pankow, Josef Coresh, Frederick L Brancati. N Engl J Med 2010
956
10

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
K Eeg-Olofsson, J Cederholm, P M Nilsson, B Zethelius, A-M Svensson, S Gudbjörnsdóttir, B Eliasson. J Intern Med 2010
101
10


Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes.
S Rodríguez-Segade, J Rodríguez, J M García López, F F Casanueva, F Camiña. Diabet Med 2012
29
10

Hypothesis: the 'metabolic memory', the new challenge of diabetes.
M A Ihnat, J E Thorpe, A Ceriello. Diabet Med 2007
112
10

Glycemic variability: both sides of the story.
Antonio Ceriello, Eric S Kilpatrick. Diabetes Care 2013
61
10



Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients.
José A Gimeno-Orna, Francisco J Castro-Alonso, Beatriz Boned-Juliani, Luis M Lou-Arnal. J Diabetes Complications 2003
52
10

Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes.
J Smith-Palmer, M Brändle, R Trevisan, M Orsini Federici, S Liabat, W Valentine. Diabetes Res Clin Pract 2014
104
10

HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes.
K Hietala, J Wadén, C Forsblom, V Harjutsalo, J Kytö, P Summanen, P-H Groop. Diabetologia 2013
44
10

Glycemic variability and diabetes retinopathy: a missing link.
Cherng-Ru Hsu, Yu-Tsung Chen, Wayne H-H Sheu. J Diabetes Complications 2015
34
10



HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patients.
Julia M Hermann, Hans-Peter Hammes, Birgit Rami-Merhar, Joachim Rosenbauer, Morten Schütt, Erhard Siegel, Reinhard W Holl. PLoS One 2014
49
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.